Erin Carter
Director/Board Member bei GLUCOTRACK, INC.
Profil
Erin Carter is currently the Director at GlucoTrack, Inc. Ms. Carter previously worked as the Vice President-Accounting & Reporting at UnitedHealth Group, Inc. Ms. Carter also served as the Assistant Controller at Arterial Vascular Engineering, Inc. Ms. Carter obtained an undergraduate degree from California Polytechnic State University (San Luis Obispo).
Aktive Positionen von Erin Carter
| Unternehmen | Position | Beginn |
|---|---|---|
| GLUCOTRACK, INC. | Director/Board Member | 25.08.2023 |
Ehemalige bekannte Positionen von Erin Carter
| Unternehmen | Position | Ende |
|---|---|---|
Arterial Vascular Engineering, Inc.
 Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Corporate Officer/Principal | 01.05.2000 |
| UNITEDHEALTH GROUP INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Erin Carter
| California Polytechnic State University (San Luis Obispo) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNITEDHEALTH GROUP INC. | Health Services |
| GLUCOTRACK, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Arterial Vascular Engineering, Inc.
Arterial Vascular Engineering, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Arterial Vascular Engineering, Inc. is a private company that makes a variety of stent systems and balloon angioplasty catheters. The company is based in Santa Rosa, CA. The company was founded by Simon H. Stertzer. Arterial Vascular Engineering was acquired by Medtronic, Inc., part of Medtronic Plc from January 27, 2015 on January 28, 1999 for $3,441.52 million. | Health Technology |
